Phase II trial of gemcitabine and docetaxel in patients with completely resected stage IIA–IIIA non-small-cell lung cancer

被引：4
|
作者：
Masafumi Kawamura
Keisuke Eguchi
Yotaro Izumi
Yasushi Yamato
Teruaki Koike
Hirozo Sakaguchi
Enjo Hada
Koichi Kobayashi
机构：
[1] Keio University Hospital,Division of General Thoracic Surgery
[2] Niigata Prefectural Cancer Center Hospital,undefined
[3] Mitsui Memorial Hospital,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2007年 / 60卷
关键词：
Non-platinum doublet; Adjuvant chemotherapy; Non-small-cell lung cancer; Docetaxel; Gemcitabin; Surgery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：495 / 501
页数：6
相关论文
共 50 条
  • [1] Phase II trial of gemcitabine and docetaxel in patients with completely resected stage IIA-IIIA non-small-cell lung cancer
    Kawamura, Masafumi
    Eguchi, Keisuke
    Izumi, Yotaro
    Yamato, Yasushi
    Koike, Teruaki
    Sakaguchi, Hirozo
    Hada, Enjo
    Kobayashi, Koichi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (04) : 495 - 501
  • [2] A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIa non-small-cell lung cancer.
    Keller, SM
    Adak, S
    Wagner, H
    Herskovic, A
    Komaki, R
    Brooks, BJ
    Perry, MC
    Livingston, RB
    Johnson, DH
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (17): : 1217 - 1222
  • [3] A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer
    Reiko Sakurai
    Yoshio Tomizawa
    Akihiro Yoshii
    Yosuke Miura
    Hiroaki Tsurumaki
    Kyoichi Kaira
    Noriaki Sunaga
    Osamu Kawashima
    Takeshi Hisada
    Masanobu Yamada
    Ryusei Saito
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 103 - 109
  • [4] A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer
    Sakurai, Reiko
    Tomizawa, Yoshio
    Yoshii, Akihiro
    Miura, Yosuke
    Tsurumaki, Hiroaki
    Kaira, Kyoichi
    Sunaga, Noriaki
    Kawashima, Osamu
    Hisada, Takeshi
    Yamada, Masanobu
    Saito, Ryusei
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (01) : 103 - 109
  • [5] Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer
    Scagliotti, GV
    Fossati, R
    Torri, V
    Crinó, L
    Giaccone, G
    Silvano, G
    Martelli, M
    Clerici, M
    Cognetti, F
    Tonato, M
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (19): : 1453 - 1461
  • [6] Phase II trial of gemcitabine, docetaxel, and cetuximab in advanced non-small-cell lung cancer (NSCLC)
    Rubinsak, J. R.
    Spigel, D. R.
    Hainsworth, J. D.
    Webb, C.
    Inhorn, R. C.
    Infante, J. R.
    Yardley, D. A.
    Burris, H. A., III
    Vazquez, E. R.
    Greco, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Role of adjuvant therapy in resected stage II/IIIA non-small-cell lung cancer
    Movsas, B
    ONCOLOGY-NEW YORK, 2002, 16 (01): : 90 - +
  • [8] A phase III randomized trial of postoperative adjuvant therapy in Stage II or IIIA completely resected non-small cell lung cancer
    Yoon, S
    Choi, E
    Kim, S
    Suh, C
    Lee, J
    Shim, T
    Kim, W
    Kim, D
    Park, S
    Park, C
    LUNG CANCER, 2005, 49 : S288 - S288
  • [9] Phase II trial of gemcitabine in advanced non-small-cell lung cancer
    Malayeri, R
    Ulsperger, E
    Baumgartner, G
    Forstner, B
    Aigner, K
    Hubner, M
    Kummer, F
    Krajnik, G
    Zochbauer, S
    Krejcy, K
    Huber, H
    Pirker, R
    WIENER KLINISCHE WOCHENSCHRIFT, 1997, 109 (17) : 688 - 691
  • [10] Phase II trial of docetaxel and vinorelbine in patients with advanced non-small-cell lung cancer
    Miller, VA
    Krug, LM
    Ng, KK
    Pizzo, B
    Perez, W
    Heelan, RT
    Kris, MG
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) : 1346 - 1350
12345